Question 1

Are benzodiazepines ever appropriate anymore, or should I avoid them entirely?

Accepted Answer

Global guidelines diverge sharply: NICE restricts to 2-4 weeks maximum; BAP acknowledges that duration limits reflect absence of evidence, not evidence of harm; WFSBP v3 (2022-2023) permits long-term use in treatment-resistant cases without substance use disorder; RANZCP permits maintenance in 'a small number of patients.' ASAM 2025 adopts a harm-reduction framework, endorsing continued benzodiazepine use when discontinuation attempts fail. The dementia signal has been substantially attenuated by prospective studies (Gray 2016 BMJ, vom Hofe 2024 BMC Medicine). Attribution bias is critical: anxiety itself causes cognitive decline and falls—the same outcomes blamed on benzodiazepines. Seppala 2018 found SSRIs carry higher fall risk (OR 2.02) than benzodiazepines (OR 1.42). The real problem is population-level overprescribing from primary care, not appropriate psychiatric use.

Question 2

What did the 2025 ASAM guidelines actually say about benzodiazepine use?

Accepted Answer

Global guidelines diverge sharply: NICE restricts to 2-4 weeks maximum; BAP acknowledges that duration limits reflect absence of evidence, not evidence of harm; WFSBP v3 (2022-2023) permits long-term use in treatment-resistant cases without substance use disorder; RANZCP permits maintenance in 'a small number of patients.' ASAM 2025 adopts a harm-reduction framework, endorsing continued benzodiazepine use when discontinuation attempts fail. The dementia signal has been substantially attenuated by prospective studies (Gray 2016 BMJ, vom Hofe 2024 BMC Medicine). Attribution bias is critical: anxiety itself causes cognitive decline and falls—the same outcomes blamed on benzodiazepines. Seppala 2018 found SSRIs carry higher fall risk (OR 2.02) than benzodiazepines (OR 1.42). The real problem is population-level overprescribing from primary care, not appropriate psychiatric use.

Question 3

When is a short-term benzodiazepine bridge still considered acceptable?

Accepted Answer

Global guidelines diverge sharply: NICE restricts to 2-4 weeks maximum; BAP acknowledges that duration limits reflect absence of evidence, not evidence of harm; WFSBP v3 (2022-2023) permits long-term use in treatment-resistant cases without substance use disorder; RANZCP permits maintenance in 'a small number of patients.' ASAM 2025 adopts a harm-reduction framework, endorsing continued benzodiazepine use when discontinuation attempts fail. The dementia signal has been substantially attenuated by prospective studies (Gray 2016 BMJ, vom Hofe 2024 BMC Medicine). Attribution bias is critical: anxiety itself causes cognitive decline and falls—the same outcomes blamed on benzodiazepines. Seppala 2018 found SSRIs carry higher fall risk (OR 2.02) than benzodiazepines (OR 1.42). The real problem is population-level overprescribing from primary care, not appropriate psychiatric use.

Question 4

What alternatives should I try before reaching for a benzodiazepine?

Accepted Answer

Global guidelines diverge sharply: NICE restricts to 2-4 weeks maximum; BAP acknowledges that duration limits reflect absence of evidence, not evidence of harm; WFSBP v3 (2022-2023) permits long-term use in treatment-resistant cases without substance use disorder; RANZCP permits maintenance in 'a small number of patients.' ASAM 2025 adopts a harm-reduction framework, endorsing continued benzodiazepine use when discontinuation attempts fail. The dementia signal has been substantially attenuated by prospective studies (Gray 2016 BMJ, vom Hofe 2024 BMC Medicine). Attribution bias is critical: anxiety itself causes cognitive decline and falls—the same outcomes blamed on benzodiazepines. Seppala 2018 found SSRIs carry higher fall risk (OR 2.02) than benzodiazepines (OR 1.42). The real problem is population-level overprescribing from primary care, not appropriate psychiatric use.

PsychHQ

Are Benzodiazepines Acceptable Anymore? A Narrative of Competing Guidelines